GT
CRDF icon

Glenview Trust’s Cardiff Oncology CRDF Stock Holding History

Glenview Trust’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.9K Hold
43,128
– – ﹤0.01% 496
2025
Q4 		$121K Hold
43,128
– – ﹤0.01% 485
2025
Q3 		$88.8K Hold
43,128
– – ﹤0.01% 484
2025
Q2 		$136K Buy
43,128
+19,150
+80% +$58.4K ﹤0.01% 497
2025
Q1 		$75.3K Hold
23,978
– – ﹤0.01% 472
2024
Q4 		$104K Buy
+23,978
New +$74.9K ﹤0.01% 476

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Glenview Trust's CRDF Position: Q1 2026 in Review

Glenview Trust held its Cardiff Oncology (CRDF) position steady in Q1 2026 at 43,128 shares worth $69.9K. The position accounts for ﹤0.01% of the portfolio, ranked #496.

Glenview Trust first reported a position in CRDF in Q4 2024 and has held it in 6 quarters since. The position peaked at $136K in Q2 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Glenview Trust held 43,128 shares of Cardiff Oncology worth $69.9K as of Q1 2026.
  • Glenview Trust left its Cardiff Oncology share count unchanged in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Glenview Trust's portfolio in Q1 2026, its #496 holding.
  • Glenview Trust first reported a position in Cardiff Oncology in Q4 2024 and has held it in 6 quarters since.
  • Glenview Trust's Cardiff Oncology position peaked at $136K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.